Pooled-funding for Clinical Trials with Osondu Ogbuoji

headshot of Osondu Ogbuoji

Dr. Osondu Ogbuoji, Assistant Research Professor at the Duke Global Health Institute and Deputy Director at the Duke Center for Policy Impact in Global Health, presented research on a pooled-funding mechanism for clinical trials at the February CHDS seminar. The mechanism is designed to reduce disease burden of poverty-related and neglected diseases in low and middle-income countries.

Dr. Ogbuoji highlighted the pressing need for funding in this area, especially for expensive, late-stage clinical trials – a stage in the research and development (R&D) pipeline where promising new technologies often fail to attract the necessary funding from existing sources. The World Health Organization and others are developing a proposal for a pooled R&D fund to fill this gap. Dr. Ogbuoji presented an ongoing study from his team that aims to estimate the potential costs and benefits of such a funding mechanism.

This seminar is the second in a series of monthly online seminars hosted by CHDS. To be added to the email list for future seminars send a note to CHDS@HSPH.harvard.edu.

Learn more: Read about Osondu Ogbuoji and his work.
Learn more: Read about Markov Modeling and Discrete Event Simulation in Health Care: a Systematic Comparison

Related news: Forecasting COVID-19 with Nicholas Reich
Related news: Livestream: HIV Testing Seminar